Summary.-A study is presented of the rate of metastatic spread of osteosarcoma. The series consists of 123 tumours in long bones and 26 elsewhere in the skeleton. All tumours occurred in otherwise normal bones and were histologically proven. With a few stated exceptions all the cases were consecutively registered.
THE appallingly high mortalitv of human osteosarcoma, which in the United Kingdom is still of the ultimate order of 85040, has largely been due to the inadequacy of any treatment for metastases. Were this not so, the cure rate could be dramatically increased to about 700o, which is equal to the proportion of these tumours arising in the long bones and which usuallv provide nearly threequarters of any series of cases. During the past decade the universally poor 5 year survival rates, which range from nil to 3000, have stimulated an active search for some means of restraining metastatic spread, e.g., by pre-operative ligation of the veins draining the tumour site (Kuehn, Tamoney and Gossling, 1970) , by prophylactic irradiation of the lungs (Newton, 1973 : Jenkin, 1973 or by immunotherapy (Marcove et al., 1973: Enneking and Marsh, 1973) .
A vigorous attack has also been launched upon overt pulmonary secondaries with chemotherapy bv Cortes et al. (1973) , Rosen et al. (1973) , Jaffe (1972) and other workers. Infusion of cvtotoxic drugs into the bronchial arteries has been reported by Ohno (1971) and multiple resections for presumed solitary secondaries have been carried out by Martini et al. (1971) .
This more aggressive attitude towards metastatic osteosarcoma, especially of lungs, has resulted in the situation that now in many centres relatively few patients-particularly juveniles-will be treated solely by surgery or radiotherapy. Thus the time is past for more precise determination of the rate of metastatic dissemination of tumours treated bv these two original and accepted techniques.
Osteosarcoma is relatively uncommon. The annual incidence of this tumour, arising in otherwise normal bones, is estimated at between 2 and 3 tumours/106 population from the records of the Bristol Bone Tumour Registry, 1946-72 (Owen, 1973) 
MATERIALS A-ND METHODS
The cases included in this study are consecutive registrations, all tumours being proven histologically. For each patient the following information has been obtained from the case notes and radiographs:
1. The nature of the treatment and date of amputation and/or commencement of radiotherapy.
2. The time when metastases have first been either clinically or radiographically evident. Where this has not been recorded, due to the absence of regular monthly annotations or radiographs, the following assumptions have been made: (a) The duration of the DFI for each individual has been calculated from the time of commencement of radiotherapy or amputation, whichever has been the earlier; (b) The maximum duration of the DPI is calculated to the month when there is first evidence of metastatic disease (either clinical or radiological; (c) The minimum duration of the DFI is calculated to one mnth folowning the last known negaire chest film or clinical annotation of no erident metast,ses; (d) WNhen only the date of death is recorded, it is assumed that metastases were evident one month before that time. All deaths within 5 years have been due to tumour.
3. The crude survival and DFI data are plotted at monthly intervals. The DFI curves are shown as maximum and minimum estimates for the number of patients without overt metastases at any one month on the time scale. The mean DFI curves are con*ructed from the arithmetic means of maximum and minimum estimates. 4. The cases are analysed by groups. Series A-Long bones only. Group Al: 53 patients treated by amputation or disarticulation. Radiotherapy or other treatment may have been used after amputation for subsequent local recurrence or metastasis, but not for the primary tumour (Fig. 1 ).
Group A2: 50 patients treated by radiotherapy. After not less than one month from completion of treatment, ablation of the tumour-bearing leg was carried out for 19 patients, and similarly for an arm in 3 patients (Fig. 2) immediately consequent or within one month of completion of the course of irradiation (Fig. 3 ).
Comparable data of metastatic fiequency for these three groups of patients are given in Table I . Series B-All other sites (26). Fig. 6 demonstrates the crude survival and DFI curves for these patients. The great majority were treated by radiotherapy; 2 patients, moribund when first seen, were excluded.
RESUJLTS
Series A. Long bone tumours (Fig. 1, 2, 3 Fig. 7 . In Group A3 16 patients received 220/250 kV radiotherapy.
The effect of patient8' age.-Long bones only (Figs. 4, 5 ).-Throughout the duration of 36 months after treatment, both the crude survival and mean DFI are better for older patients (25 years). This was noted in a previous study (Price, 1966) . All curves again tend to flatten out 24 months from the time of completing treatment. The differences between the 2 age groups are not statistically significant.
The effect of sex.-Long bones only (Table JI1 ).-Although the crude and mean disease-free survival rates are slightly better for females, the differences are not statistically significant. (1 calvarium, 1 vertebra), both dying from local spread within one month of their first being seen. The more rapid metastatic spread and shorter survival for this group may be noted from Fig. 6 . At 5 years the crude survival rate and diseasefree survivors were respectively 12% and 8%0. Jenkin (1973) and Marcove et al. (1973) are those most closely comparable with the present study. Marcove et al. (1973) and Enneking and Marsh (1973) DFI but also provides early information of metastatic spread, for which active treatment should be instituted. ObviousIv, great caution is required in the interpretation of data derived from small groups of cases. Fig. 8 indicates the 9500 confidence limits from small groups of 5, 10 and 25 cases estimated from the observed data according to the formulap 2 times the standard error which is calculated as Jx q n where p is the percentage disease-free, q = 100 -p, and n is the number of cases. (Bradford Hill, 1971) . To achieve a meaningful result in 3 years, it would be necessarv to collect records of at least 25 patients, consisting of all available long bone osteosarcoma cases in one year from a population of about 15 million persons (Fig. 8) 
